231 related articles for article (PubMed ID: 28528775)
1. Structural Basis for Apelin Control of the Human Apelin Receptor.
Ma Y; Yue Y; Ma Y; Zhang Q; Zhou Q; Song Y; Shen Y; Li X; Ma X; Li C; Hanson MA; Han GW; Sickmier EA; Swaminath G; Zhao S; Stevens RC; Hu LA; Zhong W; Zhang M; Xu F
Structure; 2017 Jun; 25(6):858-866.e4. PubMed ID: 28528775
[TBL] [Abstract][Full Text] [Related]
2. Apelin binding to human APJ receptor leads to biased signaling.
Kumar P; Ashokan A; Aradhyam GK
Biochim Biophys Acta; 2016 Dec; 1864(12):1748-1756. PubMed ID: 27671350
[TBL] [Abstract][Full Text] [Related]
3. Elabela/Toddler and apelin bind differently to the apelin receptor.
Couvineau P; Llorens-Cortes C; Iturrioz X
FASEB J; 2020 Jun; 34(6):7989-8000. PubMed ID: 32301550
[TBL] [Abstract][Full Text] [Related]
4. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationship and physiological role of apelin and its G protein coupled receptor.
Murali S; Aradhyam GK
Biophys Rev; 2023 Feb; 15(1):127-143. PubMed ID: 36919024
[TBL] [Abstract][Full Text] [Related]
6. International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.
Read C; Nyimanu D; Williams TL; Huggins DJ; Sulentic P; Macrae RGC; Yang P; Glen RC; Maguire JJ; Davenport AP
Pharmacol Rev; 2019 Oct; 71(4):467-502. PubMed ID: 31492821
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants on extracellular loop domains that dictate interaction between β-arrestin and human APJ receptor.
Ashokan A; Kameswaran M; Aradhyam GK
FEBS Lett; 2019 Mar; 593(6):634-643. PubMed ID: 30801688
[TBL] [Abstract][Full Text] [Related]
8. Effective Use of Empirical Data for Virtual Screening against APJR GPCR Receptor.
Manoliu LCE; Martin EC; Milac AL; Spiridon L
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443478
[TBL] [Abstract][Full Text] [Related]
9. Critical APJ receptor residues in extracellular domains that influence effector selectivity.
Ashokan A; Harisankar HS; Kameswaran M; Aradhyam GK
FEBS J; 2021 Nov; 288(22):6543-6562. PubMed ID: 34076959
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Ligand and Receptor Tracking through NMR Spectroscopy Enabled by Distinct
Simmons JR; Murza A; Lumsden MD; Kenward C; Marsault É; Rainey JK
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357423
[TBL] [Abstract][Full Text] [Related]
11. A patent review of apelin receptor (APJR) modulators (2014-2019).
Fischer C
Expert Opin Ther Pat; 2020 Apr; 30(4):251-261. PubMed ID: 32066307
[No Abstract] [Full Text] [Related]
12. Structure-guided discovery of a single-domain antibody agonist against human apelin receptor.
Ma Y; Ding Y; Song X; Ma X; Li X; Zhang N; Song Y; Sun Y; Shen Y; Zhong W; Hu LA; Ma Y; Zhang MY
Sci Adv; 2020 Jan; 6(3):eaax7379. PubMed ID: 31998837
[TBL] [Abstract][Full Text] [Related]
13. Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases.
Zhong JC; Zhang ZZ; Wang W; McKinnie SMK; Vederas JC; Oudit GY
Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1942-1950. PubMed ID: 27825851
[TBL] [Abstract][Full Text] [Related]
14. Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking.
Langelaan DN; Reddy T; Banks AW; Dellaire G; Dupré DJ; Rainey JK
Biochim Biophys Acta; 2013 Jun; 1828(6):1471-83. PubMed ID: 23438363
[TBL] [Abstract][Full Text] [Related]
15. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.
Cai X; Bai B; Zhang R; Wang C; Chen J
Sci Rep; 2017 Jan; 7():40335. PubMed ID: 28091541
[TBL] [Abstract][Full Text] [Related]
16. Structural insight into apelin receptor-G protein stoichiometry.
Yue Y; Liu L; Wu LJ; Wu Y; Wang L; Li F; Liu J; Han GW; Chen B; Lin X; Brouillette RL; Breault É; Longpré JM; Shi S; Lei H; Sarret P; Stevens RC; Hanson MA; Xu F
Nat Struct Mol Biol; 2022 Jul; 29(7):688-697. PubMed ID: 35817871
[TBL] [Abstract][Full Text] [Related]
17. New structural insights into the apelin receptor: identification of key residues for apelin binding.
Gerbier R; Leroux V; Couvineau P; Alvear-Perez R; Maigret B; Llorens-Cortes C; Iturrioz X
FASEB J; 2015 Jan; 29(1):314-22. PubMed ID: 25359495
[TBL] [Abstract][Full Text] [Related]
18. Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor.
Nyimanu D; Kuc RE; Williams TL; Bednarek M; Ambery P; Jermutus L; Maguire JJ; Davenport AP
Peptides; 2019 Nov; 121():170139. PubMed ID: 31472173
[TBL] [Abstract][Full Text] [Related]
19. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.
Livnah O; Stura EA; Johnson DL; Middleton SA; Mulcahy LS; Wrighton NC; Dower WJ; Jolliffe LK; Wilson IA
Science; 1996 Jul; 273(5274):464-71. PubMed ID: 8662530
[TBL] [Abstract][Full Text] [Related]
20. Apelin/APJ system as a therapeutic target in diabetes and its complications.
Hu H; He L; Li L; Chen L
Mol Genet Metab; 2016 Sep; 119(1-2):20-7. PubMed ID: 27650065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
